NLRP3炎性小体在中枢神经系统疾病中的作用研究进展

doi:10.13418/j.issn.1001-165x.2022.1.24

PDF(515 KB)

中国临床解剖学杂志 ›› 2022, Vol. 40 ›› Issue (1) : 113-116. DOI: 10.13418/j.issn.1001-165x.2022.1.24

综述

NLRP3炎性小体在中枢神经系统疾病中的作用研究进展

张鹏飞¹，　于春泽¹，　于建云²，　杨力¹*

作者信息 +

New progress of the roles of NLRP3 inflammasomes in central nervous system diseases

Zhang Pengfei¹，Yu Chunze¹，Yu Jianyun²， Yang Li¹*

Author information +

文章历史 +

导出引用

张鹏飞, 于春泽, 于建云, 杨力. NLRP3炎性小体在中枢神经系统疾病中的作用研究进展[J]. 中国临床解剖学杂志. 2022, 40(1): 113-116 https://doi.org/10.13418/j.issn.1001-165x.2022.1.24

Zhang Pengfei, Yu Chunze, Yu Jianyun, Yang Li. New progress of the roles of NLRP3 inflammasomes in central nervous system diseases[J]. Chinese Journal of Clinical Anatomy. 2022, 40(1): 113-116 https://doi.org/10.13418/j.issn.1001-165x.2022.1.24

中图分类号： R363.21

参考文献

[1] Zhu S, Ding SY, Wang PH, et al. Nlrp9b inflammasome restricts rotavirus infection in intestinal epithelial cells[J]. Nature, 2017, 546(7660): 667-670. DOI: 10.1038/nature22967.
[2] Karki R, Kanneganti TD. Diverging inflammasome signals in tumorigenesis and potential targeting[J]. Nat Rev Cancer, 2019, 19(4): 197-214. DOI: 10.1038/s41568-019-0123-y.
[3] Liu W, Chen YH, Meng J, et al. Ablation of caspase-1 protects against TBI-induced pyroptosis in vitro and in vivo[J]. J Neuroinflammation, 2018, 15(1): 48. DOI: 10.1186/s12974-018-1083-y.
[4] O'Brien WT, Pham L, Symons GF, et al. The NLRP3 inflammasome in traumatic brain injury: potential as a biomarker and therapeutic target[J]. J Neuroinflammation, 2020, 17(1): 104. DOI: 10.1186/s12974-020-01778-5.
[5] Xu X, Yin DP, Ren HL, et al. Selective NLRP3 inflammasome inhibitor reduces neuroinflammation and improves long-term neurological outcomes in a murine model of traumatic brain injury[J]. Neurobiol Dis, 2018, 117: 15-27. DOI: 10.1016/j.nbd.2018.05.016.
[6] Wallisch JS, Simon DW, Bayir H, et al. Cerebrospinal fluid NLRP3 is increased after severe traumatic brain injury in infants and children[J]. Neurocrit Care, 2017, 27(1): 44-50. DOI: 10.1007/s12028-017-0378-7.
[7] Geng FY, Ma YH, Xing T, et al. Effects of hyperbaric oxygen therapy on inflammasome signaling after traumatic brain injury[J]. Neuroimmunomodulation, 2016, 23(2): 122-129. DOI: 10.1159/000445689.
[8] Severini C, Barbato C, Di Certo MG, et al. Alzheimer's disease: new concepts on the role of autoimmunity and of NLRP3 inflammasome in the pathogenesis of the disease[J]. Curr Neuropharmacol, 2020. DOI: 10.2174/1570159X18666200621204546.
[9] Abbott A. Is 'friendly fire' in the brain provoking Alzheimer's disease[J]? Nature, 2018, 556(7702): 426-428. DOI: 10.1038/d41586-018-04930-7.
[10]Zhang Y, Dong ZF, Song WH. NLRP3 inflammasome as a novel therapeutic target for Alzheimer's disease[J]. Signal Transduct Target Ther, 2020, 5(1): 37. DOI: 10.1038/s41392-020-0145-7.
[11]Ising C, Venegas C, Zhang SS, et al. NLRP3 inflammasome activation drives tau pathology[J]. Nature, 2019, 575(7784): 669-673. DOI: 10.1038/s41586-019-1769-z.
[12]Mao Z, Liu C, Ji S, et al. The NLRP3 inflammasome is involved in the pathogenesis of Parkinson's disease in rats[J]. Neurochem Res, 2017, 42(4): 1104-1115. DOI: 10.1007/s11064-017-2185-0.
[13]Qiao C, Zhang Q, Jiang QL, et al. Inhibition of the hepatic Nlrp3 protects dopaminergic neurons via attenuating systemic inflammation in a MPTP/p mouse model of Parkinson's disease[J]. J Neuroin flammation, 2018, 15(1): 193. DOI: 10.1186/s12974-018-1236-z.
[14]Lee JD, Kumar V, Fung JN, et al. Pharmacological inhibition of complement C5a-C5a1 receptor signalling ameliorates disease pathology in the hSOD1(G93A) mouse model of amyotrophic lateral sclerosis[J]. Br J Pharmacol, 2017, 174(8): 689-699. DOI: 10.1111/bph.13730.
[15]Bellezza I, Grottelli S, Costanzi E, et al. Peroxynitrite activates the NLRP3 inflammasome cascade in SOD1(G93A) mouse model of amyotrophic lateral sclerosis[J]. Mol Neurobiol, 2018, 55(3): 2350-2361. DOI: 10.1007/s12035-017-0502-x.
[16]Inoue M, Williams KL, Gunn MD, et al. NLRP3 inflammasome induces chemotactic immune cell migration to the CNS in experimental autoimmune encephalomyelitis[J]. Proc Natl Acad Sci U S A, 2012, 109(26): 10480-10485. DOI: 10.1073/pnas.1201836109.
[17]Zhou KQ, Green CR, Bennet L, et al. The role of connexin and pannexin channels in perinatal bBrain injury and inflammation[J]. Front Physiol, 2019, 10: 141. DOI: 10.3389/fphys.2019.00141.
[18]Zhao J, Piao XY, Wu Y, et al. Cepharanthine attenuates cerebral ischemia/reperfusion injury by reducing NLRP3 inflammasome-induced inflammation and oxidative stress via inhibiting 12/15-LOX signaling[J]. Biomed Pharmacother, 2020, 127: 110151. DOI: 10.1016/j.biopha.2020.110151.
[19]Wang HN, Zhong D, Chen HP, et al. NLRP3 inflammasome activates interleukin-23/interleukin-17 axis during ischaemia-reperfusion injury in cerebral ischaemia in mice[J]. Life Sci, 2019, 227: 101-113. DOI: 10.1016/j.lfs.2019.04.031.
[20]Ye XC, Shen T, Hu JX, et al. Purinergic 2X7 receptor/NLRP3 pathway triggers neuronal apoptosis after ischemic stroke in the mouse[J]. Exp Neurol, 2017, 292: 46-55. DOI: 10.1016/j.expneurol.2017.03.002.
[21]Mohamadi Y, Noori Moghahi SMH, Mousavi M, et al. Intrathecal transplantation of Wharton's jelly mesenchymal stem cells suppresses the NLRP1 inflammasome in the rat model of spinal cord injury[J]. J Chem Neuroanat, 2019, 97: 1-8. DOI: 10.1016/j.jchemneu.2019.01.011.
[22]Su XQ, Wang XY, Gong FT, et al. Oral treatment with glycyrrhizin inhibits NLRP3 inflammasome activation and promotes microglial M2 polarization after traumatic spinal cord injury[J]. Brain Res Bull, 2020, 158: 1-8. DOI: 10.1016/j.brainresbull.2020.02.009.
[23]Wang SN, Guo XY, Tang J, et al. Expression and localization of absent in melanoma 2 in the injured spinal cord[J]. Neural Regen Res, 2019, 14(3): 542-552. DOI: 10.4103/1673-5374.245481.
[24]Ramaswamy V, Walsh JG, Sinclair DB, et al. Inflammasome induction in Rasmussen's encephalitis: cortical and associated white matter pathogenesis[J]. J Neuroinflammation, 2013, 10: 152. DOI: 10.1186/1742-2094-10-152.
[25]Yue J, Wei YJ, Yang XL, et al. NLRP3 inflammasome and endoplasmic reticulum stress in the epileptogenic zone in temporal lobe epilepsy: molecular insights into their interdependence[J]. Neuropathol Appl Neurobiol, 2020, 46(7): 770-785. DOI: 10.1111/nan.12621.
[26]Chen ML, Lin K, Lin SK. NLRP3 inflammasome signaling as an early molecular response is negatively controlled by miR-186 in CFA-induced prosopalgia mice[J]. Braz J Med Biol Res, 2018, 51(9): e7602. DOI: 10.1590/1414-431X20187602.
[27]Zhong ZY, Liang S, Sanchez-Lopez E, et al. New mitochondrial DNA synthesis enables NLRP3 inflammasome activation[J]. Nature, 2018, 560(7717): 198-203. DOI: 10.1038/s41586-018-0372-z.
[28]Christgen S, Place DE, Kanneganti TD. Toward targeting inflammasomes: insights into their regulation and activation[J]. Cell Res, 2020, 30(4): 315-327. DOI: 10.1038/s41422-020-0295-8.
[29]Kelley N, Jeltema D, Duan YH, et al. The NLRP3 inflammasome: an overview of mechanisms of activation and regulation[J]. Int J Mol Sci, 2019, 20(13): 3328. DOI: 10.3390/ijms20133328.
[30]Samir P, Kesavardhana S, Patmore DM, et al. DDX3X acts as a live-or-die checkpoint in stressed cells by regulating NLRP3 inflammasome[J]. Nature, 2019, 573(7775): 590-594. DOI: 10.1038/s41586-019-1551-2.